Burford Execs Bet $4.3M on 'Undervalued' Stock Amid Market Doubts

NEW YORK, NY – March 09, 2026 – In a powerful display of insider confidence, top executives at Burford Capital have plowed over $4.3 million of their own cash compensation into the company's stock, a move the firm’s chief executive says is a direct response to a significant market mispricing.

The substantial investment, disclosed in a company announcement, comes at a time when Burford's stock has been lagging, creating a stark contrast between management’s bullish outlook and recent market sentiment. The move is coupled with a new share repurchase program and long-term incentive grants, painting a picture of a leadership team determined to align its interests with shareholders and prove the market wrong.

A Major Vote of Confidence

On March 5, four of Burford Capital's senior leaders, including its two most prominent executives, collectively purchased more than 500,000 of the company's ordinary shares. Chief Executive Officer Christopher Bogart led the charge by acquiring approximately 228,264 shares, while Chief Investment Officer Jonathan Molot purchased a nearly identical 229,794 shares. Chief Financial Officer Jordan Licht and Chief Development Officer Travis Lenkner also participated with smaller, yet significant, investments.

These purchases were not made on the open market but through the company's Deferred Compensation Plan, allowing the executives to convert their cash pay directly into equity. The move signals a profound belief in the company's future, as articulated by the CEO.

"We believe Burford's stock is priced at a steep discount to its intrinsic value," commented Christopher Bogart. He emphasized this isn't a one-time gesture, noting, "Since 2019, Jon and I have redeployed cash compensation into Burford's stock on several occasions, amounting to net purchases in excess of $35 million. Our combined shareholding has risen to approximately 8.5% of the Company, a level of management ownership that provides strong alignment with external shareholders."

This strong insider buying, however, comes as the company's stock (NYSE: BUR) has faced headwinds. In the past week, the share price has fallen approximately 11%, trading near its 52-week low. Over the last 12 months, the stock has delivered a negative total return of nearly 37%, starkly underperforming the S&P 500's 14% gain in the same period. This divergence highlights a significant disconnect between how the company's leaders and the broader market are currently valuing the litigation finance giant.

The Valuation Debate

Bogart's assertion of a "steep discount" is at the heart of the current narrative surrounding Burford. On one hand, the sentiment among financial analysts largely supports his view. The consensus rating on the stock is a "strong buy," with an average price target of $17.70, representing a potential upside of over 120% from its recent closing price. Forecasts from some analysts reach as high as $22.50 per share. This optimism is bolstered by the company's unique position as a leader in the specialized field of legal finance.

However, a closer look at traditional valuation metrics presents a more complex picture. The company's price-to-earnings (P/E) ratio stands at approximately 27.2, which is considerably higher than the peer average of 11.3x and the U.S. Diversified Financial industry average of 18.6x. This suggests the stock is trading at a premium compared to its earnings. Yet, other metrics tell a different story. Its price-to-book (P/B) ratio is a low 0.74, a figure that often indicates a stock may be undervalued relative to the company's net assets.

This mixed financial data suggests that investors are weighing the company's dominant market position and growth potential against its current profitability and recent stock performance. The executive team is clearly betting that the company's intrinsic value, derived from its vast portfolio of legal assets, will eventually be recognized by the market, closing the gap analysts have identified.

Aligning Incentives for the Long Haul

Beyond the personal investments, Burford's board is reinforcing its message through structured corporate actions. The company has authorized a $5.0 million share repurchase program, which will be used to acquire its own shares on the open market. These repurchased shares are intended to fulfill future obligations under the same Deferred Compensation Plan used by the executives, effectively creating a self-sustaining cycle of incentive alignment.

Share buybacks can provide support for a stock's price by reducing the number of shares outstanding and signaling that the company itself considers its stock a good investment. The program will operate under rules that govern timing and volume, depending on market conditions.

In a parallel move, Burford also issued new grants of restricted share units (RSUs) to its executive team as part of its annual compensation cycle under the 2025 Omnibus Incentive Compensation Plan. For most executives, these RSUs vest in five equal installments over five years, from 2027 through 2031. This long vesting period is a standard corporate governance tool designed to retain key talent and tie their financial outcomes directly to the long-term success of the company.

Interestingly, for the most senior, retirement-eligible executives—including Bogart, Molot, and Chief Strategy Officer Elizabeth O'Connell—the newly granted RSUs vested immediately. However, the actual settlement and delivery of the shares will still occur over the same multi-year schedule, ensuring their continued financial linkage to the company's performance well into the future. These actions collectively demonstrate a multi-pronged strategy to ensure that management's focus remains squarely on delivering sustained shareholder value over the next half-decade.